Geopolitics Alpha

Market closed · last trade · ETF proxies, Alpaca IEX

Johnson Winter Slattery guides on acquisition of women’s health specialist pharma company

Published . Updated .

Key takeaways

  • The acquisition will boost the buyers’ position within the women’s health sector in Europe and globally.
  • Exposed: VGK, JNJ, LLY, PFE, MRK
  • Market reaction: price tracking starts with the next trading session.

Market Call

Think this story will push the stock up or down over the next three trading days? Make a free call and see what other readers think. Points are play money with no cash value.

Get these market calls by email

The week's biggest market-moving stories, Congress trades and Trump posts, with the tickers they touch. Free, one email a week.

Free. We only use your email to send the digest and never sell or share it. See our privacy policy.

Johnson Winter Slattery guides on acquisition of women’s health specialist pharma company

The acquisition will boost the buyers’ position within the women’s health sector in Europe and globally.

Indirectly affected

  • XLV Health Care Select Sector SPDR

    Health Care Select Sector SPDR: it holds drugmakers and health companies. Linked by “pharma” (pharma and health) in this story.

  • XBI SPDR S&P Biotech ETF

    SPDR S&P Biotech ETF: it holds drugmakers and health companies. Linked by “pharma” (pharma and health) in this story.

  • VGK Vanguard FTSE Europe ETF

    Vanguard FTSE Europe ETF holds stocks listed in Europe, which this story is about (“europe”).

  • JNJ Johnson & Johnson+12.1% 30d

    Johnson & Johnson (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “pharma” (pharma and health) in this story.

  • LLY Eli Lilly and+25.1% 30d

    Eli Lilly and (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “pharma” (pharma and health) in this story.

  • PFE Pfizer+5.2% 30d

    Pfizer (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “pharma” (pharma and health) in this story.

  • MRK Merck+3.5% 30d

    Merck (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “pharma” (pharma and health) in this story.

Price reaction, T-5 to T+3

TickerT-5T-3T-1T0T+1T+2T+3
XLV+3.66%+3.71%baseafter closeafter closeafter closeafter close
XBI+4.22%+0.59%baseafter closeafter closeafter closeafter close
VGKPrices arriving within minutes———after closeafter closeafter closeafter close
JNJ+3.98%+3.63%baseafter closeafter closeafter closeafter close
LLY+3.43%+3.72%baseafter closeafter closeafter closeafter close
PFE+2.74%+2.92%baseafter closeafter closeafter closeafter close
MRK+6.65%+4.90%baseafter closeafter closeafter closeafter close

Closing-price change versus T-1, the last close before the story. T0 to T+3 fill in after each market close. Prices: Alpaca IEX.

Johnson Winter Slattery guides on acquisition of women’s health specialist pharma company ICLG

Source: ICLG

This story

CompanyWhenMoveStatus
JNJthree days earlier+3.63%final price
JNJfive days earlier+3.98%final price
LLYthree days earlier+3.72%final price
LLYfive days earlier+3.43%final price
MRKthree days earlier+4.90%final price
MRKfive days earlier+6.65%final price
PFEthree days earlier+2.92%final price
PFEfive days earlier+2.74%final price
XBIthree days earlier+0.59%final price
XBIfive days earlier+4.22%final price
XLVthree days earlier+3.71%final price
XLVfive days earlier+3.66%final price

Trades by members of Congress and officials in the stocks in this story

Public disclosure filings, not a recommendation. The filing link is the source document. News use of these reports still sits under 5 U.S.C. § 13107(c).

This story

12 out of 100

“Johnson Winter Slattery guides on acquisition of women’s health specialist pharma company” scores 12 out of 100. The score uses 1 source.